The US Foods and Drug Administration(FDA) on Monday approved Biogen's aducanumab drug for Alzheimer's patience. Breaking news: The FDA has approved Aducanumab, the first FDA-approved drug that delays decline due to Alzheimer’s.

In major breakthrough, US FDA approves new Alzheimer's drug

The antibody showed 'almost complete clearance' of sticky proteins that clot in the brain, a reason that is believed to cause the disease

Trial drug kindles hopes of Alzheimer's treatment

aducanumab

Aducanumab, News on Aducanumab, stories on Aducanumab, articles on Aducanumab, Aducanumab stories at Wion, Aducanumab news, Aducanumab latest news